FDA NDC Directory · JSON-LD · Markdown

XYOSTED

NDC 54436-200 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nametestosterone enanthate
Labeler / ManufacturerAntares Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209863
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsTESTOSTERONE ENANTHATE (100 mg/.5mL)
Marketing started20181115
Package count3

External sources

Source: openFDA. Public-domain (CC0).